Market forecast analyses for West Nile virus (WNV) vaccine and anti-WNV monoclonal antibody for prophylaxis
Key Dates
Due Date
-
Posted Date
-
Agency & Value
Agency
CDC OFFICE OF ACQUISITION SERVICES
Contract Value
Not provided
Codes & Classification
Solicitation Number
97469
NAICS
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Classification Code
AN11
Additional Details
Documents2
The Centers for Disease Control and Prevention (CDC), through its Office of Acquisition Services, has issued a combined synopsis/solicitation (RFQ No. 75D301-26-Q-79208) seeking contractor support for comprehensive market forecast analyses related to West Nile virus (WNV) prevention. This procurement is conducted under FAR Subpart 12.6 for commercial services, utilizing simplified acquisition procedures as outlined in FAR Part 13. The opportunity is classified under Product Service Code AN11 (Health R&D Services, Epidemiology) and NAICS Code 541715 (Research and Development in the Physical, Engineering, and Life Sciences, except Nanotechnology and Biotechnology).
Purpose and Scope:
The primary objective of this procurement is to obtain expert analytical services to support the CDC’s National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), specifically the Division of Vector-Borne Diseases (DVBD). The contractor will be responsible for conducting two distinct market forecast analyses: one for a human West Nile virus (WNV) vaccine and another for an anti-WNV monoclonal antibody (mAb) intended for seasonal pre-exposure prophylaxis. These analyses are intended to inform public health strategies, guide future investments, and support the development and deployment of effective WNV prophylactic interventions.
Key Requirements and Deliverables:
The contractor’s responsibilities will encompass a broad range of activities, including:
- Market forecasting for both the WNV vaccine and anti-WNV monoclonal antibody.
- Epidemiologic analyses to assess disease burden and target populations.
- Health economic modeling to evaluate cost-effectiveness and potential impact.
- Stakeholder engagement to gather insights from relevant parties.
- Commercial assessments and financial analyses to determine market viability.
- Preparation of peer-reviewed publications to disseminate findings.
All services and deliverables must adhere to the requirements and schedule detailed in the attached Statement of Work (SOW), with monthly invoicing expected. Deliverables are to be submitted according to the timeline specified in Section 7 of the SOW.
Contract Details:
- Contract Type: Time-and-Materials (T&M) purchase order.
- Period of Performance: 12 months, from September 30, 2026, through September 29, 2027.
- Place of Performance: Atlanta, Georgia, United States.
Submission and Compliance:
Interested offerors must provide:
- Completed pricing for all Contract Line Item Numbers (CLINs).
- A comprehensive Time-and-Materials quotation covering the full period of performance.
- Written acknowledgment of the SOW, confirming the ability to fulfill all requirements.
- Proof of active registration in the System for Award Management (SAM), including a Unique Entity Identifier (UEI) and no active exclusions.
- Any required Artificial Intelligence (AI) disclosures and an AI Compliance and Risk Management Plan, if applicable.
Special Considerations:
This solicitation is open to qualified vendors capable of delivering high-quality market and epidemiological analyses in accordance with federal acquisition regulations. There are no explicit set-aside requirements or special restrictions noted in the notice. Offerors should ensure compliance with all submission requirements and be prepared to engage with CDC stakeholders throughout the contract period.
Contracting Entity and Contact Information:
- Contracting Entity: CDC Office of Acquisition Services, Department of Health and Human Services
- Agency: Centers for Disease Control and Prevention
- Primary Contact: Iris Gonzalez ([email protected])
- Place of Performance: Atlanta, Georgia (GA), USA
Timeline and Additional Information:
- Notice posted: August 26, 2026
- Due date for all quotes: September 2, 2026, at 10:00 AM EST
- Opportunity status: Active
- Additional documents, including a Q&A and the Statement of Work, are available via the SAM.gov opportunity listing (Opportunity ID: 32e4662962b14cf1ad982872c815470a).
This opportunity is well-suited for contractors with demonstrated expertise in epidemiology, health economics, market analysis, and scientific publication, particularly within the context of infectious disease prevention. Interested parties are encouraged to review the full Statement of Work and ensure all submission requirements are met by the specified deadline.